Clin Kidney J. 2021;14(6):1673-1680.
Increasing prescription of renin-angiotensin-aldosterone system blockers associated with improved kidney prognosis in Korean IgA nephropathy patients.
제1저자 박세훈 · 교신저자 이하정
소속 (11)
- Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, Korea.
- Department of Internal Medicine, Armed Forces Capital Hospital, Gyeonggi-do, Korea.
- Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
- Department of Pediatrics, Seoul National University Hospital, Seoul, Korea.
- Korean GlomeruloNEphritis sTudy (KoGNET) Group, Korean Society of Nephrology, Seoul, Korea.
- Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.
- Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea.
- Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea.
- Kidney Research Institute, Seoul National University, Seoul, Korea.
- Department of Pathology, Seoul National University Hospital, Seoul, Korea.
- Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul, Korea.
Abstract
BACKGROUND We aimed to describe the characteristics of immunoglobulin A nephropathy (IgAN) in Korea with assessment for time trends.
METHODS We performed a multicenter retrospective observational cohort study including biopsy-confirmed native IgAN cases from four tertiary hospitals in Korea. Time eras of diagnosis were stratified into 1979-2003, 2004-9 and 2010-17. The prognostic variable was progression to end-stage kidney disease (ESKD) analyzed by multivariable Cox regression analysis.
RESULTS We included 1366 (from 1979 to 2003), 1636 (from 2004 to 2009) and 1442 (from 2010 to 2017) IgAN patients in this study. In the recent periods, IgAN had relatively better clinical characteristics, as patients had higher estimated glomerular filtration rates and lower baseline blood pressures than before. The use of renin-angiotensin-aldosterone system (RAAS) blockers increased from 57.7% in 1979-2003 to 80.0% in 2010-17. During a median follow-up duration of 11.3 years, 722 patients progressed to ESKD with an incidence rate of 12.5 per 1000 person-years. The 10-year risk of progression to ESKD was lower in 2010-17 compared with that of 1979-2003 [adjusted hazard ratio 0.692 (95% confidence interval 0.523-0.915)], even after adjustment for multiple clinicopathologic characteristics. The use of RAAS blockers was a significant mediator (P < 0.001) for the association between time trends and lower 10-year ESKD risk.
CONCLUSIONS Clinicopathologic characteristics of IgAN in Korea have changed over time. Although the limitation of a retrospective observational study remains, the result showed that the prognosis of IgAN has improved over the study period, possibly related to increased prescription of RAAS blockers.
© The Author(s) 2020. Published by Oxford University Press on behalf of ERA-EDTA.
Keywords
IgA nephropathyaldosterone receptor blockadeangiotensin-converting enzyme inhibitorend-stage kidney diseaseglomerulonephritis
Figures
그림 출처: PubMed Central 공개 논문 (PMC8162855)
그 밖의 정보
- 출판 형태
- Journal Article
- 저널
- Clinical kidney journal · ISSN 2048-8505
- 전자 출판
- 2020-12-11
- 참고문헌
- 35편